King, B.; Soung, J.; Tziotzios, C.; Rudnicka, L.; Joly, P.; Gooderham, M.; Sinclair, R.; Anway, S.; Wajsbrot, D.; Lejeune, A. .; Zwillich, S. Integrated Safety Analysis of Ritlecitinib for the Treatment of Alopecia Areata (AA) From the Phase 2 and Phase 3 ALLEGRO Clinical Trial Program. J of Skin 2023, 7, s291.